Functionalization with ApoE-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide

Journal of Biotechnology

Volumn 156, Issue 4, 2011, Pages 341-346

  Re, Francesca ^a   Cambianica, Ilaria ^a   Sesana, Silvia ^a   Salvati, Elisa ^a   Cagnotto, Alfredo ^b   Salmona, Mario ^b   Couraud, Pierre Olivier ^c   Moghimi, S Moein ^d   Masserini, Massimo ^a   Sancini, Giulio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c INSTITUT COCHIN   (France)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alzheimer's disease; ApoE peptide; Beta amyloid peptide; Brain capillary endothelial cells; Nanoliposomes

Indexed keywords

AMINO ACIDS; CYTOLOGY; GLYCOPROTEINS; GROWTH KINETICS; LIPOSOMES; NANOPARTICLES; NEURODEGENERATIVE DISEASES; PEPTIDES; PHOSPHOLIPIDS; SYNTHESIS (CHEMICAL); TARGETED DRUG DELIVERY;

ACIDIC PHOSPHOLIPIDS; ALZHEIMER'S DISEASE; AMYLOID-BETA PEPTIDES; BETA AMYLOID PEPTIDES; BRAIN CAPILLARY ENDOTHELIAL CELLS; NANOLIPOSOMES; NANOPARTICLE SURFACE; PHYSICAL CHARACTERIZATION;

ENDOTHELIAL CELLS;

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; CYSTEINE; DIMER; LIPOSOME; NANOLIPOSOME; NANOPARTICLE; PHOSPHATIDIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN CAPILLARY ENDOTHELIUM CELL; CARBOXY TERMINAL SEQUENCE; CELL INTERACTION; CELL TRANSPORT; CONFOCAL LASER MICROSCOPY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

EID: 82955195917     PISSN: 01681656     EISSN: 18734863     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2011.06.037     Document Type: Article

References (18)

1. Bhaskar S., Tian F., Stoeger T., Kreyling W., de la Fuente J.M., Grazú V., Borm P., Estrada G., Ntziachristos V., Razansky D. Multifunctional nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Particle Fibre Toxicol. 2010, 7:3.
2. Bu G. Apolipoprotein, E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009, 10:333-344.
3. Cerletti A., Drewe J., Fricker G., Eberle A.N., Huwyler J. Endocytosis and transcytosis of an immunoliposome-based brain drug delivery system. J. Drug Target. 2000, 8:435-446.
4. Dartigues J.F. Alzheimer's disease: a global challenge for the 21st century. Lancet Neurol. 2009, 8:1082-1083.
5. de Boer A.G., Gaillard P.J. Drug targeting to the brain. Ann. Rev. Pharmacol. Toxicol. 2007, 47:323-355.
6. Dehouck B., Dehouck M.P., Fruchart J.C., Cecchelli R. Upregulation of the low-density lipoprotein receptor at the blood-brain barrier: intercommunications between brain capillary endothelial cells and astrocytes. J. Cell Biol. 1994, 126:465-473.
7. Gobbi M., Re F., Canovi M., Beeg M., Gregori M., Sesana S., Sonnino S., Brogioli D., Musicanti C., Gasco P., Salmona M., Masserini M. Lipid-based nanoparticles with high binding affinity for amyloid-beta-1-42 peptide. Biomaterials 2010, 31:6519-6529.
8. Hulsermann U., Hoffmann M.M., Massing U., Fricker G. Uptake of apolipoprotein E fragment coupled liposomes by cultured brain microvessel endothelial cells and intact brain capillaries. J. Drug Target. 2009, 17:610-618.
9. Jeynes B., Provias J. The case for blood-brain barrier dysfunction in the pathogenesis of Alzheimer's disease. J. Neurosci. Res. 2011, 89:22-28.
10. Laskowitz D.T., Thekdi A.D., Thekdi S.D., Han S.K., Myers J.K., Pizzo S.V. Downregulation of microglial activation by apolipoprotein E and apoE-mimetic peptides. Exp. Neurol. 2001, 167:74-85.
11. Lui J.K., Laws S.M., Li Q.X., Villemagne V.L., Ames D., Brown B., Bush A.I., De Ruyck K., Dromey J., Ellis K.A., Faux N.G., Foster J., Fowler C., Gupta V., Hudson P., Laughton K., Masters C.L., Pertile K., Rembach A., Rimajova M., Rodrigues M., Rowe C.C., Rumble R., Szoeke C., Taddei K., Taddei T., Trounson B., Ward V., Martins R.N. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. J. Alzheimers Dis. 2010, 20:1233-1242.
12. Markoutsa E., Pampalakis G., Niarakis A., Romero I.A., Weksler B., Couraud P.O., Antimisiaris S.G. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line. Eur. J. Pharm. Biopharm. 2011, 77:265-274.
13. Matsuoka Y., Saito M., LaFrancois J., Saito M., Gaynor K., Olm V., Wang L., Casey E., Lu Y., Shiratori C., Lemere C., Duff K. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to beta-amyloid. J. Neurosci. 2003, 23:29-33.
14. Michaelis K., Hoffmann M.M., Dreis S., Herbert E., Alyautdin R.N., Michaelis M. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J. Pharmacol. Exp. Ther. 2006, 317:1246-1253.
15. Sauer I., Dunay I.R., Weisgraber K., Bienert M., Dathe M. An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells. Biochemistry 2005, 44:2021-2029.
16. Tai L.M., Reddy P.S., Lopez-Ramirez M.A., Davies H.A., Male D.K., Loughlin A.J., Romero I.A. Polarized P-glycoprotein expression by the immortalized human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123. Brain Res. 2009, 1292:14-24.
17. Vu K., Weksler B., Romero I., Couraud P.O., Gelli A. Immortalized human brain endothelial cell line hCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot. Cell 2009, 8(11):1803-1807.
18. Zensi A., Begley D., Pontikis C., Legros C., Mihoreanu L., Wagner S. Albumin nanoparticles targeted with ApoE enter the CNS by transcytosis and are delivered to neurons. J. Control. Release 2009, 137:78-86.